Beta-Amyloid (Aβ(1-42)) Increases the Expression of NKCC1 in the Mouse Hippocampus

Alzheimer’s disease (AD) is a neurodegenerative disorder with an increasing need for developing disease-modifying treatments as current therapies only provide marginal symptomatic relief. Recent evidence suggests the γ-aminobutyric acid (GABA) neurotransmitter system undergoes remodeling in AD, disr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Patricia, Vinnakota, Chitra, Guzmán, Beatriz Calvo-Flores, Newland, Julia, Peppercorn, Katie, Tate, Warren P., Waldvogel, Henry J., Faull, Richard L. M., Kwakowsky, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027496/
https://www.ncbi.nlm.nih.gov/pubmed/35458638
http://dx.doi.org/10.3390/molecules27082440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027496/
https://www.ncbi.nlm.nih.gov/pubmed/35458638
http://dx.doi.org/10.3390/molecules27082440

Ejemplares similares